Biomarker-guided antibiotic use in primary care in resource-constrained environments

Research output: Contribution to journalComment/debateResearchpeer-review

Standard

Biomarker-guided antibiotic use in primary care in resource-constrained environments. / Aabenhus, Rune; Stæhr Jensen, Jens-Ulrik.

In: The Lancet Global Health, Vol. 4, No. 9, 09.2016, p. e586-e587.

Research output: Contribution to journalComment/debateResearchpeer-review

Harvard

Aabenhus, R & Stæhr Jensen, J-U 2016, 'Biomarker-guided antibiotic use in primary care in resource-constrained environments', The Lancet Global Health, vol. 4, no. 9, pp. e586-e587. https://doi.org/10.1016/S2214-109X(16)30170-X

APA

Aabenhus, R., & Stæhr Jensen, J-U. (2016). Biomarker-guided antibiotic use in primary care in resource-constrained environments. The Lancet Global Health, 4(9), e586-e587. https://doi.org/10.1016/S2214-109X(16)30170-X

Vancouver

Aabenhus R, Stæhr Jensen J-U. Biomarker-guided antibiotic use in primary care in resource-constrained environments. The Lancet Global Health. 2016 Sep;4(9):e586-e587. https://doi.org/10.1016/S2214-109X(16)30170-X

Author

Aabenhus, Rune ; Stæhr Jensen, Jens-Ulrik. / Biomarker-guided antibiotic use in primary care in resource-constrained environments. In: The Lancet Global Health. 2016 ; Vol. 4, No. 9. pp. e586-e587.

Bibtex

@article{4f17e8f06b9b44b4ab3b0954b80e5ef5,
title = "Biomarker-guided antibiotic use in primary care in resource-constrained environments",
author = "Rune Aabenhus and {St{\ae}hr Jensen}, Jens-Ulrik",
year = "2016",
month = sep,
doi = "10.1016/S2214-109X(16)30170-X",
language = "English",
volume = "4",
pages = "e586--e587",
journal = "The Lancet Global Health",
issn = "2214-109X",
publisher = "The Lancet Publishing Group",
number = "9",

}

RIS

TY - JOUR

T1 - Biomarker-guided antibiotic use in primary care in resource-constrained environments

AU - Aabenhus, Rune

AU - Stæhr Jensen, Jens-Ulrik

PY - 2016/9

Y1 - 2016/9

U2 - 10.1016/S2214-109X(16)30170-X

DO - 10.1016/S2214-109X(16)30170-X

M3 - Comment/debate

VL - 4

SP - e586-e587

JO - The Lancet Global Health

JF - The Lancet Global Health

SN - 2214-109X

IS - 9

ER -

ID: 166939202